dihydrosanguinarine has been researched along with nadp in 1 studies
Studies (dihydrosanguinarine) | Trials (dihydrosanguinarine) | Recent Studies (post-2010) (dihydrosanguinarine) | Studies (nadp) | Trials (nadp) | Recent Studies (post-2010) (nadp) |
---|---|---|---|---|---|
28 | 0 | 17 | 21,608 | 25 | 3,484 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, YJ; Liu, ZY; Sun, ZL; Zhang, DS | 1 |
1 other study(ies) available for dihydrosanguinarine and nadp
Article | Year |
---|---|
NQO1 involves in the imine bond reduction of sanguinarine and recombinant adeno-associated virus mediated NQO1 overexpression decreases sanguinarine-induced cytotoxicity in rat BRL cells.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Benzophenanthridines; Biotransformation; Cell Proliferation; Cell Survival; Cytochrome P-450 CYP1A1; Dependovirus; Dose-Response Relationship, Drug; Genetic Vectors; HEK293 Cells; Humans; Isoquinolines; Liver; NAD(P)H Dehydrogenase (Quinone); NADP; Oxidation-Reduction; Proto-Oncogene Proteins c-bcl-2; Rats; Time Factors; Transfection | 2014 |